type here...

CATEGORIES

Press Release

LATEST

1...789...12Page 8 of 12

TRENDING

EDITORS CHOICE

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

Medika Life -
Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Global Empowerment Mission in Partnership with Bethenny Frankel’s BStrong Initiative Align with NCS Group for Texas Aid Relief During The State of Emergency

Medika Life -
The LATEST mission is bringing three relief trucks to Texas with the first truck en route from Miami to Denton (The Cross Timbers Hope Center In Denton, TX) followed by Houston, TX on Tuesday (February 23)

INOVIO Receives $71 Million Contract From U.S. Department of Defense

Medika Life -
CELLECTRA® 3PSP is designed to deliver INO-4800 directly into the skin, where the vaccine prompts the body's immune system to drive a robust immune response

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories